acromegaly

BIM-23190 aceate 是一种生长抑素类似物，一种 SSTR2 和 SSTR5 的选择性激动剂。 BIM-23190 可用于癌症和肢端肥大症研究。

Octreotide (SMS 201-995) 是一种有效的生长激素、胰高血糖素和胰岛素抑制剂。它主要与生长抑素 2、3 和 5 亚型受体结合，可增强 Gi 活性，降低胞内 cAMP 的产生。

BIM-23190 is a somatostatin analog that acts as a selective agonist for SSTR2 and SSTR5 receptors. It displays potency with K i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 finds utility in cancer and acromegaly research.

BIM-23190 hydrochloride, a selective agonist for somatostatin receptors SSTR2 and SSTR5 with Ki values of 0.34 nM and 11.1 nM respectively, is a somatostatin analog utilized in research on cancer and acromegaly[1][3].

Lanreotide, a somatostatin analogue, suppresses GH IGF-I hypersecretion in acromegaly patients. It also used to manage neuroendocrine tumours.